Unique compounds that can be used for inducing an immune response to
Borrelia burgdorferi
in a subject by administering a therapeutically effective amount of the glycolipid to the subject. Such administration is particularly useful for preventing or treating Lyme disease in a subject. The compounds(s), and therapeutically acceptable salts thereof, may be formulated into pharmaceutical or immunogenic compositions.
本发明涉及一种独特的化合物,可通过向受试者投与治疗有效量的
糖脂来诱导免疫反应,从而在受试者中预防或治疗莱姆病。该化合物(及其治疗上可接受的盐)可制成药物或免疫原组合物。